Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acetaminophen Market

Acetaminophen Market Analysis

  • Report ID: GMI5935
  • Published Date: Jun 2023
  • Report Format: PDF

Acetaminophen  Market Analysis

By dosage form, the acetaminophen market is classified into tablets, liquid suspension, infusion solutions, and other dosage forms. The tablet dosage form is the most popular and is expected to occupy majority of the share in the global market. Since tablets are easy to take orally, the segment is expected to grow rapidly in the coming years. Also, tablets are widely used because of their convenience, ease of administration, accurate dosing, and stability. They can be manufactured in various shapes, sizes, and colours, and can be designed to release the active ingredient in a specific manner to achieve the desired therapeutic effect. Therefore, because of rapid pain relief and availability of combination dosages with other pain killers, the segment is anticipated to witness high growth, thereby enhancing the market revenue.
 

Acetaminophen Market Revenue Share, By Route of Administration,

Based on route of administration, the acetaminophen market is segmented into oral, parenteral, and other routes of administration. The parenteral route of administration is expected to register around USD 1.3 billion by 2032. The parenteral route offers direct and rapid delivery of the drug into the bloodstream. This ensures more efficient and predictable absorption of the drugs, resulting in faster onset of action and improved treatment outcomes. Therefore, healthcare professionals and patients are increasingly opting for parenteral administration of paracetamol, thereby propelling market demand.  
 

By application, the acetaminophen market is segmented into pain relief & fever, common cold, headache, and abdominal cramps. The pain relief and fever segment held largest market share of 76.4% in 2022. Paracetamol is a commonly used medicine used to treat pain and reduce a high temperature. It is typically used to relieve mild or moderate pain, such as headaches, toothache, or sprains, and reduce fevers caused by illnesses such as colds and flu. The sale of paracetamol for pain relief and fever has surged in high-growth countries, such as India and China, because of the simplicity of procurement. Furthermore, an increase in the number of people suffering from pain and fever, as well as improved awareness, is one of the important causes for market advancement.
 

The distribution channel in acetaminophen market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies accounted for USD 3.4 billion market revenue in 2022. High market share of the hospital pharmacies segment can be attributed to high patient load in hospitals. Also, availability of a wide range of treatments within the hospital setting will boost the segment size. Additionally, the advanced pharmaceutical infrastructure and expertise of hospital pharmacies, including compounding capabilities, allow for personalized and tailored treatments, further contributing to the market growth.
 

North America Acetaminophen Market Size,

North America region holds the largest market share of global acetaminophen market. The presence of key players, high incidence of fever, headaches, migraine in the region, well-structured healthcare system are some of the key factors that drive the regional market expansion. The market growth in the U.S. is expected to be robust during the forecast period. For instance, according to the Migraine Research Foundation, more than 4 million adults experience chronic daily migraines, with at least 15 migraine days per month in the U.S. Thus, the growing patient pool and increasing disposable revenue in this country are expected to boost the market share.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Acetaminophen market size was USD 9.8 billion in 2022 and will record over 4.8% CAGR between 2023 to 2032.

The parenteral route of administration segment will reach around USD 1.3 billion by the end of 2032 as it offers direct and rapid delivery of the drug into the bloodstream.

North America holds the largest regional share in acetaminophen market due to the presence of key players, high incidence of fever, headaches, migraine, and a well-structured healthcare system.

BRISTOL-MYERS SQUIBB, Bayer AG, Sun Pharmaceutical Industries Limited, Glaxo SmithKline Pharmaceuticals Ltd, Alkem Laboratories Ltd, Abbott, B.BRAUN MELSUNGEN, Novartis AG, IOL Chemicals and Pharmaceuticals, Lupin Ltd, and Teva Pharmaceuticals USA, Inc.

Acetaminophen Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 268
  • Countries covered: 20
  • Pages: 180
 Download Free Sample